Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/12/2010CA2198586C Mutant enterotoxin effective as a non-toxic oral adjuvant
10/12/2010CA2196570C Recombinant herpesvirus of turkeys and uses thereof
10/12/2010CA2151547C Recombinant chimeric proteins and methods of use thereof
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010115053A2 Methods of using canonical wnts as enhancers for bone formation by human bone-marrow derived mesenchymal stem cells
10/07/2010WO2010115032A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010WO2010114938A1 Soluble hydrolyzed keratin production
10/07/2010WO2010114860A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010WO2010114828A1 Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
10/07/2010WO2010114797A1 Protein-assisted drug delivery system for the targeted administration of active agents for overcoming blood-brain barrier
10/07/2010WO2010114628A2 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
10/07/2010WO2010114616A1 A peg-albumin composition having at least one protected thiol region as a platform for medications
10/07/2010WO2010114275A2 Composition for inhibiting erythema caused by ultraviolet radiation containing a dipeptide as active ingredient
10/07/2010WO2010114129A1 T cell receptor and nucleic acid encoding the receptor
10/07/2010WO2010113753A1 Prophylactic or therapeutic agent for retinal diseases and method for preventing or treating retinal diseases, each comprising jnk (c-jun n-terminal kinase)-inhibiting peptide, and use of the peptide
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
10/07/2010WO2010113146A1 A method of regulating proliferation and differentiation of keratinocyes
10/07/2010WO2010113042A1 Antimicrobial cyclic peptides
10/07/2010WO2010112988A1 Method for production of lactoferrin
10/07/2010WO2010112848A2 Inhibition of biofilm organisms
10/07/2010WO2010112713A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112712A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010112711A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112710A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010112707A1 Use of a bartonella adhesin fragment for a vaccine
10/07/2010WO2010112678A1 Regenerative matrix comprising cells activated by nemosis and/or factors released from such cells
10/07/2010WO2010112556A1 Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury
10/07/2010WO2010112546A1 Process for making a milk-based protein hydrolysate
10/07/2010WO2010112471A1 Pro-apoptotic peptides
10/07/2010WO2010112430A1 Improvement in promotion of healthy catch-up growth
10/07/2010WO2010111910A1 Synthetic peptide and uses thereof
10/07/2010WO2010111845A1 A high specific activity human menopausal gonadotropin, preparation method and use thereof
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111792A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010WO2010111789A1 Inhibition of formation of advanced glycation endproducts
10/07/2010WO2010111753A1 Compositions and methods for treatment of aortic fibrosis
10/07/2010WO2010093843A3 Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir
10/07/2010WO2010092571A3 Short beta-defensin-derived peptides
10/07/2010WO2010082176A3 Compositions containing kxk type peptides
10/07/2010WO2010077093A3 Composition for promoting hair growth or preventing hair loss comprising erythropoietin
10/07/2010WO2010072843A3 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells
10/07/2010WO2010071894A3 Tfpi inhibitors and methods of use
10/07/2010WO2010071767A3 Na/k-atpase-derived peptide src inhibitors and ouabain antagonists and uses thereof
10/07/2010WO2010070136A3 Novel caviidae allergens and uses thereof
10/07/2010WO2010042225A3 Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides
10/07/2010WO2010041913A9 Novel uses of grs proteins or fragments thereof
10/07/2010WO2010015665A3 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
10/07/2010WO2010011890A3 Cancer peptide therapeutics
10/07/2010WO2009106986A3 Nonstructural protein ns1 as a novel therapeutic target against flaviviruses: use of inhibiting molecules interfering with ns1 maturation or biological activity
10/07/2010WO2009100505A8 Immunogenic peptides and their use in transplantation
10/07/2010WO2005072159A3 Biotherapeutics, diagnostics and research reagents
10/07/2010WO2001079455A9 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/07/2010US20100257618 Micro-RNA-Based Methods and Compositions for the Diagnosis and Treatment of Colon Cancer-Related Diseases
10/07/2010US20100256756 Sericin extracted fabrics
10/07/2010US20100256330 Peptide-based compounds
10/07/2010US20100256075 High Yield Secretion of Multimeric Recombinant Protein
10/07/2010US20100256074 Processes for preparing high purity aza cyclohexapeptides
10/07/2010US20100256073 Therapeutic agent comprising lipocalin 2 against cancer metastasis, and methods of early diagnosis and inhibition of cancer metastasis using lipocalin 2
10/07/2010US20100256072 Therapeutic agents for the treatment of leukemia
10/07/2010US20100256071 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
10/07/2010US20100256070 Recombinant vibrio cholerae exotoxins
10/07/2010US20100256069 Targeted induction of aggregation of proteins with cross beta structures
10/07/2010US20100256068 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/07/2010US20100256066 Active soluble post-translationally modified neuregulin isoforms
10/07/2010US20100256065 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor
10/07/2010US20100256064 Delivery device and method
10/07/2010US20100256063 Method for Increasing Cardiac Mass and Performance
10/07/2010US20100256062 Allelic Variants of Human Factor VIII
10/07/2010US20100256061 Gastrin compound for diabetes treatment
10/07/2010US20100256060 Peptide pharmaceuticals for nasal delivery
10/07/2010US20100256059 Regulation of immune responses by modulation of the function of antigen presenting cells
10/07/2010US20100256058 Exercise performance and recovery formulations
10/07/2010US20100256057 Method of preventing or treating body weight disorders by employing clusterin
10/07/2010US20100256056 Analogues of exendin-4 and exendin-3
10/07/2010US20100256055 Conjugates of neurotensin or neurotensin analogs and uses thereof
10/07/2010US20100256050 Composition for preventing virus infection comprising poly-gamma-glutamic acid
10/07/2010US20100256049 Macrolactone derivatives
10/07/2010US20100256048 Polypeptide compound
10/07/2010US20100256047 Analyte Measurement and Management Device and Associated Methods
10/07/2010US20100256046 Treatment of proliferative disorders
10/07/2010US20100256045 Use of Measles Virus Nucleoprotein for Treating Atherosclerosis
10/07/2010US20100256044 Peptides with improved properties having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100256042 Methods of using chimeric coiled-coil molecule
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100256040 Composition and method for treating viral infection
10/07/2010US20100256039 Control of copolymer compositions
10/07/2010US20100256038 Th-17 cells
10/07/2010US20100255579 Tumor antigen protein and use thereof
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255535 Novel gene upregulated in cancers of the prostate
10/07/2010US20100255502 Methods for Detecting and Inhibiting Angiogenesis
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255491 Mammalian selenoprotein differentially expressed in tumor cells
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255111 Intraperitoneal Delivery of Genetically Engineered Mesenchymal Stem Cells
10/07/2010US20100255100 Stabilized protein crystals, formulations comprising them and methods of making them
10/07/2010US20100255098 Stereocomplex hydrogels
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255078 Serpin drugs for treatment of viral infection and method of use thereof
1 ... 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 ... 3163